Cullinan Therapeutics

CGEM · NASDAQ

$14.83+$0.85 (+6.08%)TodayMarket closed ·
Prev close $13.98

Who owns CGEM

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 75.6% of CGEM’s shares.

  • MPM BioImpact LLC15.8%
  • Lynx1 Capital Advisors LLC14.6%
  • BVF Partners L.P.9.4%
  • BlackRock Institutional Trust Company, N.A.7.5%
  • Next 6 largest institutions28.3%
  • All other shareholders24.4%
Top institutional holders of CGEM
HolderShares% of shares
MPM BioImpact LLC9.73M15.83%
Lynx1 Capital Advisors LLC8.96M14.58%
BVF Partners L.P.5.75M9.36%
BlackRock Institutional Trust Company, N.A.4.64M7.54%
T. Rowe Price Associates, Inc.3.72M6.06%
State Street Investment Management (US)3.67M5.97%
Kynam Capital Management LP3.11M5.07%
Vanguard Capital Management, LLC2.61M4.25%
RTW Investments L.P.2.36M3.85%
Invus Public Equities Advisors, LLC1.89M3.08%

Largest mutual fund holders

Top mutual fund holders of CGEM
HolderShares% of shares
State Street SPDR S&P Biotech ETF2.51M4.08%
Vanguard Total Stock Market Index Fund1.95M3.18%
iShares Russell 2000 ETF1.57M2.56%
T. Rowe Price New Horizons Fund1.02M1.66%
Fidelity Small Cap Index Fund655.91K1.07%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $1.04M (5 trades) of CGEM on the open market, with no buys.

Latest CGEM insider transactions
InsiderTypeSharesValue
Michaelson JenniferOption exercise4.00K—
Michaelson JenniferSale8.00K$172.56K
Michaelson JenniferOption exercise4.00K$17.20K
Michaelson JenniferOption exercise30.00K—
Michaelson JenniferSale30.00K$607.80K
Michaelson JenniferOption exercise30.00K$129.00K
Michaelson JenniferOption exercise4.00K—
Michaelson JenniferSale8.00K$142.56K
Michaelson JenniferOption exercise4.00K$17.20K
SUMER JACQUELYN LAward2.47K$21.24K

Short interest

Settled Sep 30, 2026

Shares short
7.63M
Days to cover
5.07
% of shares outstanding
12.42%
Average daily volume
1.51M
Change since last report
−20.7%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.